Endocrine, Metabolic & Immune Disorders - Drug Targets

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back Subscribe
Research Article

Optimizing Care for Primary Glomerulonephritis: The Role of Thyroid Evaluation

Author(s): Ahmet Numan Demirorcid of author, Cebrail Karacaorcid of author, Zehra Karaorcid of author, Cem Suluorcid of author, Serdar Sahinorcid of author, Emre Durcanorcid of author, Mevlut Tamer Dincerorcid of author, Sukran Erdem Nurcanorcid of author, Ozge Sonmez, Hande Mefkure Ozkayaorcid of author, Nurhan Seyahiorcid of author and Mustafa Sait Gonen*

Volume 25, Issue 11, 2025

Published on: 08 January, 2025

Page: [905 - 914] Pages: 10

DOI: 10.2174/0118715303328436241121114054

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: The coexistence of primary glomerulonephritis and autoimmune thyroid disease has not been investigated.

Objective: This study aimed to assess thyroid morphology using sonography, determine the prevalence of autoimmune thyroid disorders, and evaluate thyroid function status in patients diagnosed with primary glomerulonephritis.

Materials and Methods: This single-center cross-sectional and observational study included 58 consecutive patients with primary glomerulonephritis and 58 healthy controls (HC). All participants underwent thyroid examination through laboratory tests and thyroid ultrasonography. The findings were subsequently compared between the two groups.

Results: Among the patients, 17.2% (n = 10) exhibited subclinical hypothyroidism, while 8.6% (n = 5) had overt hypothyroidism. None of the HCs showed overt hypothyroidism, whereas 3.4% (n = 2) of them exhibited subclinical hypothyroidism. Patients displayed significantly lower free triiodothyronine (FT3) levels than HCs (p < 0.001). A linear correlation was observed between patients' thyroid-stimulating hormone (TSH) levels and the degree of proteinuria (p = 0.044). Furthermore, thyroid volume (p < 0.001), hypoechogenicity (p < 0.001), heterogeneous structure (p < 0.001), pseudonodular hypoechoic infiltration (p = 0.05), and the presence of nodules (p < 0.001) were notably higher in patients compared to HCs.

Conclusion: The prevalence of both overt and subclinical hypothyroidism, along with the frequency of nodular goiter, was found to be elevated in patients with primary glomerulonephritis. Considering that primary glomerulonephritis predominantly afflicts young individuals, and these patients bear the lifelong burden of chronic kidney disease, we underscore the significance of routine thyroid function tests and sonographic examinations for the early detection of thyroid disorders.

Keywords: Nodular goiter, primary glomerulonephritis, autoimmune thyroid disease, glomerulonephritis, thyroid ultrasonography, hypothyroidism, thyroid disorders.

[1]
Pesce F, Stea ED, Rossini M, et al. Glomerulonephritis in AKI: From pathogenesis to therapeutic intervention. Front Med 2021; 7: 582272.
[http://dx.doi.org/10.3389/fmed.2020.582272]
[2]
Han Q, Xu H, Li L, Lei S, Yang M. Demographic distribution analysis of different glomerular diseases in Southwest China from 2008 to 2022. Int Urol Nephrol 2024; 56(6): 2011-20.
[http://dx.doi.org/10.1007/s11255-023-03902-9] [PMID: 38172368]
[3]
Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 2020; 16(1): 32-50.
[http://dx.doi.org/10.1038/s41581-019-0178-8] [PMID: 31399725]
[4]
Ameh OI, Ekrikpo U, Bello A, Okpechi I. Current management strategies of chronic kidney disease in resource-limited countries. Int J Nephrol Renovasc Dis 2020; 13: 239-51.
[http://dx.doi.org/10.2147/IJNRD.S242235]
[5]
Thomsen H, Li X, Sundquist K, Sundquist J, Försti A, Hemminki K. Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden. J Transl Autoimmun 2020; 3: 100058.
[http://dx.doi.org/10.1016/j.jtauto.2020.100058]
[6]
Schultheiss UT, Steinbrenner I, Nauck M, et al. Thyroid function, renal events and mortality in chronic kidney disease patients: The German chronic kidney disease study. Clin Kidney J 2020; 14(3): 959-68.
[http://dx.doi.org/10.1093/ckj/sfaa052]
[7]
Brenta G, Nepote A, Barreto A, et al. Low glomerular filtration rate values are associated with higher TSH in an elderly population at high cardiovascular disease risk. Front Endocrinol (Lausanne) 2023; 14: 1162626.
[http://dx.doi.org/10.3389/fendo.2023.1162626]
[8]
Raj R, Kumar V, Bhushan D, Biswas R, Ojha VS. The prevalence of thyroid abnormalities in patients with chronic kidney disease: A cross-sectional study at a tertiary care hospital. Cureus 2023; 15(8): e43065.
[http://dx.doi.org/10.7759/cureus.43065]
[9]
Siriwardhane T, Krishna K, Ranganathan V, et al. Significance of Anti-TPO as an early predictive marker in thyroid disease. Autoimm Dis 2019; 2019: 1684074.
[http://dx.doi.org/10.1155/2019/1684074]
[10]
Velluzzi F, Pisanu S, Galletta M, et al. Association between high normal TSH levels and obesity in women with anti-thyroid autoantibodies (ATAs). J Clin Med 2022; 11(17): 5125.
[http://dx.doi.org/10.3390/jcm11175125]
[11]
Khan SR, Peeters RP, van Hagen PM, Dalm V, Chaker L. Determinants and clinical implications of thyroid peroxidase antibodies in middle-aged and elderly individuals: The rotterdam study. Thyroid 2021; 32(1): thy.2021.0403.
[http://dx.doi.org/10.1089/thy.2021.0403] [PMID: 34779279]
[12]
Konca C, Elhan AH. Unveiling the accuracy of ultrasonographic assessment of thyroid volume: A comparative analysis of ultrasonographic measurements and specimen volumes. J Clin Med 2023; 12(20): 6619.
[http://dx.doi.org/10.3390/jcm12206619]
[13]
Liu L, Liu L, Li M, et al. Study on association between height, weight, iodine supplementation and thyroid volume. Br J Nutr 2022; 127(9): 1358-66.
[http://dx.doi.org/10.1017/S0007114521002622] [PMID: 34256883]
[14]
Willms A, Bieler D, Wieler H, Willms D, Kaiser KP, Schwab R. Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis. J Ultrasound Med 2013; 32(11): 1979-86.
[http://dx.doi.org/10.7863/ultra.32.11.1979] [PMID: 24154902]
[15]
Durcan E, Sahin S, Dedeoglu SE, Ozkaya HM, Gonen MS. Can “VAI” better indicate metabolic syndrome compared with other metabolic syndrome-related parameters in patients with thyroid nodules? A study from Turkey. Metab Syndr Relat Disord 2021; 19(6): 358-66.
[http://dx.doi.org/10.1089/met.2020.0147] [PMID: 33794138]
[16]
Wang X, Zhao X, Huang X. Association of subclinical thyroid dysfunction with chronic kidney disease: A systematic review and meta-analysis. Endocr Res 2020; 45(1): 41-9.
[http://dx.doi.org/10.1080/07435800.2019.1645164] [PMID: 31345069]
[17]
Narasaki Y, Sohn P, Rhee CM. The interplay between thyroid dysfunction and kidney disease. Semin Nephrol 2021; 41(2): 133-43.
[http://dx.doi.org/10.1016/j.semnephrol.2021.03.008] [PMID: 34140092]
[18]
Al Fahdi I, Al Salmi I, Al Rahbi F, Shaheen F, Hannawi S. Thyroid dysfunction and kidney dysfunction. Oman Med J 2022; 37(3): e377.
[http://dx.doi.org/10.5001/omj.2022.55]
[19]
Peters J, Roumeliotis S, Mertens PR, Liakopoulos V. Thyroid hormone status in patients with impaired kidney function. Int Urol Nephrol 2021; 53(11): 2349-58.
[http://dx.doi.org/10.1007/s11255-021-02800-2] [PMID: 33682051]
[20]
Sivertsson E, Friederich-Persson M, Persson P, Nangaku M, Hansell P, Palm F. Thyroid hormone increases oxygen metabolism causing intrarenal tissue hypoxia; a pathway to kidney disease. PLoS One 2022; 17(3): e0264524.
[http://dx.doi.org/10.1371/journal.pone.0264524]
[21]
Liu X, Li Y, Chai Y, Zhang Y, Zhang L, Zhang H. Thyroid function and thyroid homeostasis parameters are associated with increased urinary albumin excretion in euthyroid individuals over 60 years old from NHANES. Front Endocrinol (Lausanne) 2024; 14: 1285249.
[http://dx.doi.org/10.3389/fendo.2023.1285249]
[22]
Reinhardt W, Mülling N, Behrendt S, et al. Association between albuminuria and thyroid function in patients with chronic kidney disease. Endocrine 2021; 73(2): 367-73.
[http://dx.doi.org/10.1007/s12020-021-02640-1] [PMID: 33575899]
[23]
Yuasa R, Muramatsu M, Saito A, et al. Urinary excretion of thyroid hormone in CKD patients: A proof-of-concept of nephrogenic hypothyroidism. Ren Fail 2023; 45(2): 2293224.
[http://dx.doi.org/10.1080/0886022X.2023.2293224] [PMID: 38087476]
[24]
Jain D, Aggarwal HK, Kumar Y M P, Jain P. Evaluation of thyroid dysfunction in patients with nephrotic syndrome. Med Pharm Rep 2019; 92(2): 139-44.
[http://dx.doi.org/10.15386/mpr-1091] [PMID: 31086841]
[25]
Gilles R, den Heijer M, Ross AH, Sweep FC, Hermus AR, Wetzels JF. Thyroid function in patients with proteinuria. Neth J Med 2008; 66(11): 483-5.
[PMID: 19075315]
[26]
Kwong N, Medici M, Marqusee E, Wassner AJ. Severity of proteinuria is directly associated with risk of hypothyroidism in adults. J Clin Endocrinol Metab 2021; 106(2): e757-62.
[http://dx.doi.org/10.1210/clinem/dgaa872] [PMID: 33245743]
[27]
Echterdiek F, Ranke MB, Schwenger V, Heemann U, Latus J. Kidney disease and thyroid dysfunction: The chicken or egg problem. Pediatr Nephrol 2022; 37(12): 3031-42.
[http://dx.doi.org/10.1007/s00467-022-05640-z] [PMID: 35737115]
[28]
Małujło-Balcerska E, Pietras T. Deiodinase Types 1 and 3 and proinflammatory cytokine values may discriminate depressive disorder patients from healthy controls. J Clin Med 2023; 12(19): 6163.
[http://dx.doi.org/10.3390/jcm12196163]
[29]
Karbownik-Lewińska M, Stępniak J, Iwan P, Lewiński A. Iodine as a potential endocrine disruptor—a role of oxidative stress. Endocrine 2022; 78(2): 219-40.
[http://dx.doi.org/10.1007/s12020-022-03107-7] [PMID: 35726078]
[30]
Rao MJ, Zhang Y, Peng WZ, Pan PH. Association of thyroid hormones and thyroid-stimulating hormone with mortality in adults admitted to the intensive care unit: A systematic review and meta-analysis. J Chin Med Assoc 2022; 85(4): 443-52.
[http://dx.doi.org/10.1097/JCMA.0000000000000697] [PMID: 35125402]
[31]
Wang Z, Wang F, Liu C, Zhang L. Association of thyroid autoantibodies and diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: A cross-sectional study from a Chinese university hospital. BMJ Open 2024; 14(3): e077338.
[http://dx.doi.org/10.1136/bmjopen-2023-077338]
[32]
Huang B, Zhang Y, Wang L, et al. Phospholipase A2 receptor autoantibodies as a novel serological biomarker for autoimmune thyroid disease associated nephropathy. Front Immunol 2020; 11: 837.
[http://dx.doi.org/10.3389/fimmu.2020.00837]
[33]
Zhu W, Dong X, Pan Q, Hu Y, Wang G. The association between albuminuria and thyroid antibodies in newly diagnosed type 2 diabetes mellitus patients with Hashimoto's thyroiditis and euthyroidism. BMC Endocr Disor 2020; 20(1): 172.
[http://dx.doi.org/10.1186/s12902-020-00650-0]
[34]
Cotoi L, Borcan F, Sporea I, et al. Thyroid pathology in end-stage renal disease patients on Hemodialysis. Diagnostics 2020; 10(4): 245.
[http://dx.doi.org/10.3390/diagnostics10040245]
[35]
Yuasa R, Ohashi Y, Saito A, Tsuboi K, Shishido S, Sakai K. Prevalence of hypothyroidism in Japanese chronic kidney disease patients. Ren Fail 2020; 42(1): 572-9.
[http://dx.doi.org/10.1080/0886022X.2020.1777162] [PMID: 32567453]
[36]
Januś D, Kujdowicz M, Wójcik M. Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma - a follow-up study. Front Endocrinol (Lausanne) 2023; 14: 1172823.
[http://dx.doi.org/10.3389/fendo.2023.1172823]
[37]
Alexander LF, Patel NJ, Caserta MP, Robbin ML. Thyroid ultrasound. Radiol Clin North Am 2020; 58(6): 1041-57.
[http://dx.doi.org/10.1016/j.rcl.2020.07.003] [PMID: 33040847]
[38]
Moschos E, Mentzel HJ. Ultrasound findings of the thyroid gland in children and adolescents. J Ultrasound 2022; 26(1): 211-21.
[http://dx.doi.org/10.1007/s40477-022-00660-9] [PMID: 35138597]
[39]
Zhou P, Chen F, Zhou P, et al. The use of modified TI-RADS using contrast-enhanced ultrasound features for classification purposes in the differential diagnosis of benign and malignant thyroid nodules: A prospective and multi-center study. J Front Endocrinol (Lausanne) 2023; 14: 1080908.
[http://dx.doi.org/10.3389/fendo.2023.1080908]
[40]
Lin CC, Chen TW, Ng YY, Chou YH, Yang WC. Thyroid dysfunction and nodular goiter in hemodialysis and peritoneal dialysis patients. Perit Dial Int 1998; 18(5): 516-21.
[http://dx.doi.org/10.1177/089686089801800510] [PMID: 9848631]
[41]
Da Costa ABBA, Pellizzari C, Carvalho GA, et al. High prevalence of subclinical hypothyroidism and nodular thyroid disease in patients on hemodialysis. Hemodial Int 2016; 20(1): 31-7.
[http://dx.doi.org/10.1111/hdi.12339] [PMID: 26246426]
[42]
Sanai T, Okamura K, Inoue T, Abe T, Tsuruya K, Node K. Ultrasonographic detection of thyroid nodules in hemodialysis patients in Japan. Ther Apher Dial 2010; 14(3): 323-7.
[http://dx.doi.org/10.1111/j.1744-9987.2010.00810.x] [PMID: 20609186]